Literature DB >> 8603971

Delta APACHE II for predicting course and outcome of nosocomial Staphylococcus aureus bacteremia and its relation to host defense.

E P Yzerman1, H A Boelens, J H Tjhie, J A Kluytmans, J W Mouton, H A Verbrugh.   

Abstract

To predict at an early phase the clinical course and outcome of nosocomial Staphylococcus aureus bacteremia, the APACHE II score at onset of bacteremia was calculated in 99 patients. A delta APACHE II score (i.e., the difference between this score and one calculated for the day before the bacteremia) was also determined. This delta APACHE II score was highly significantly correlated with clinical course (P<.001) and outcome (P<.001). The risk of a complicated clinical course and of dying from S. aureus bacteremia is determined at the very onset of bacteremia, and this risk can best be assessed by calculating the delta APACHE II score. Furthermore, a positive correlation was found between delta APACHE II scores and the level of serum opsonic activity (P=.003) toward S. aureus. Therefore, the complicated clinical course of S. aureus bacteremia is not due to a relative lack of specific opsonins.

Entities:  

Mesh:

Year:  1996        PMID: 8603971     DOI: 10.1093/infdis/173.4.914

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

Review 1.  Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks.

Authors:  J Kluytmans; A van Belkum; H Verbrugh
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.

Authors:  G Fätkenheuer; M Preuss; B Salzberger; N Schmeisser; O A Cornely; H Wisplinghoff; H Seifert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-25       Impact factor: 3.267

3.  Multicenter evaluation of a modified protocol for the RAPIDEC staph system for direct identification of Staphylococcus aureus in blood cultures.

Authors:  A van Griethuysen; A Buiting; W Goessens; P van Keulen; R Wintermans; J Kluytmans
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

Review 4.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study.

Authors:  A J Kaasch; S Rieg; J Kuetscher; H-R Brodt; T Widmann; M Herrmann; C Meyer; T Welte; P Kern; U Haars; S Reuter; I Hübner; R Strauss; B Sinha; F M Brunkhorst; M Hellmich; G Fätkenheuer; W V Kern; H Seifert
Journal:  Infection       Date:  2013-03-29       Impact factor: 3.553

6.  Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.

Authors:  Marin L Schweizer; Jon P Furuno; Anthony D Harris; J Kristie Johnson; Michelle D Shardell; Jessina C McGregor; Kerri A Thom; Sara E Cosgrove; George Sakoulas; Eli N Perencevich
Journal:  BMC Infect Dis       Date:  2011-10-19       Impact factor: 3.090

7.  Immune dysfunction prior to Staphylococcus aureus bacteremia is a determinant of long-term mortality.

Authors:  Jared A Greenberg; Michael Z David; Jesse B Hall; John P Kress
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

8.  Inflammatory responses to infection: the Dutch contribution.

Authors:  Martijn A Nolte; Jos W M van der Meer
Journal:  Immunol Lett       Date:  2014-10-18       Impact factor: 3.685

Review 9.  Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers.

Authors:  Miranda van Rijen; Marc Bonten; Richard Wenzel; Jan Kluytmans
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.